The Role of Multimodality Imaging in Cardiac Sarcoidosis
- Author:
Noriko OYAMA-MANABE
1
;
Osamu MANABE
;
Tadao AIKAWA
;
Satonori TSUNETA
Author Information
- Publication Type:Review
- From:Korean Circulation Journal 2021;51(7):561-578
- CountryRepublic of Korea
- Language:English
- Abstract: The etiology and the progression of sarcoidosis remain unknown. However, cardiac sarcoidosis (CS) is significantly associated with a poor prognosis due to the associated congestive heart failure, arrhythmias (such as an advanced atrioventricular block), and ventricular tachyarrhythmia. Novel imaging modalities are now available to detect CS lesions secondary to active inflammation, granuloma formation, and fibrotic changes.18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) and cardiac magnetic resonance imaging (CMR) play essential roles in diagnosing and monitoring patients with confirmed or suspected CS. The following focused review will highlight the emerging role of non-invasive cardiac imaging techniques, including FDG PET/ CT and CMR.
